Previous Chapter: Appendix A: Committee Member and Staff Biosketches
Suggested Citation: "Appendix B: Open Session Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Veterans, Prescription Opioids and Benzodiazepines, and Mortality, 2007–2019: Three Target Trial Emulations. Washington, DC: The National Academies Press. doi: 10.17226/28584.

B

Open Session Meeting Agendas

COMMITTEE ON THE EFFECTS OF OPIOIDS AND BENZODIAZEPINES ON ALL-CAUSE MORTALITY IN VETERANS

February 3, 2023

1:00–1:05pm Welcome and Introductions; Conduct of the Open Session
Brian Strom, Committee Chair
1:05–2:00 Charge to the Committee and Background on Section 204a Hannon Act
David Atkins, VA Research Health Services Research and Development
Jodie Trafton, Program Evaluation and Resource Center for the VHA Office of Mental Health and Suicide Prevention
Friedhelm Sandbrink, Pain Management, Opioid Safety and Prescription Drug Monitoring Programs (PMOP), Specialty Care Program Office, Veterans Health Administration
2:00–2:30 Overview of Available Data Sources
Jodie Trafton, VHA Office of Mental Health and Suicide Prevention
Friedhelm Sandbrink, Acting VHA National Program Director for Pain Management
2:30–2:45 Congressional Request
Emily Blair Rubright, U.S. Senate Committee on Veterans’ Affairs
2:45–3:00 Public Comments
3:00 Open Session Ends
Suggested Citation: "Appendix B: Open Session Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Veterans, Prescription Opioids and Benzodiazepines, and Mortality, 2007–2019: Three Target Trial Emulations. Washington, DC: The National Academies Press. doi: 10.17226/28584.

March 9, 2023

9:00–9:05am Welcome
Brian Strom, Committee Chair
9:05–10:05 Panel: Trends in Opioid and Benzodiazepine Use, Addiction, and Related Overdose Secular Trends in Opioid and Benzodiazepine Use
Christopher Jones, Centers for Disease Control and Prevention
Distinguishing Between Effect of Prescription Opioids Versus Synthetic/Illicit Opioids Sequela of Opioid Addiction, Comorbid Mental Health Conditions, and Suicide Risk
William Becker, Yale School of Medicine
10:05-11:00 Panel: Data and Design Considerations
10:05–10:40 Opioid Dose Reduction Trial Emulation
Erin Krebs, Minneapolis VA Health Care System
10:40–11:00 Approaches to Examining Effects of Prescribed Opioid Use
Corey Hayes, University Arkansas for Medical Sciences
Bradley Martin, University Arkansas for Medical Sciences
11:00–11:10 Break
11:10–11:30 Data and Design: Associations Between Stopping Prescriptions and Overdose or Suicide Deaths in U.S. Veterans
Elizabeth Oliva, Department of Veterans Affairs
Jodie Trafton, Department of Veterans Affairs
11:30–12:00 Panel: Provider and Veteran Perspectives Patients’ and Providers’ Perspective on Tapering
Joseph Frank, University of Colorado
Perspectives from Veterans’ Service Organizations
Alex Balbir, Wounded Warrior Project
12:00 noon Open Session Adjourns
Suggested Citation: "Appendix B: Open Session Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Veterans, Prescription Opioids and Benzodiazepines, and Mortality, 2007–2019: Three Target Trial Emulations. Washington, DC: The National Academies Press. doi: 10.17226/28584.
Page 217
Suggested Citation: "Appendix B: Open Session Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Veterans, Prescription Opioids and Benzodiazepines, and Mortality, 2007–2019: Three Target Trial Emulations. Washington, DC: The National Academies Press. doi: 10.17226/28584.
Page 218
Next Chapter: Appendix C: Public Law 116-171
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.